Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Overview of attention for article published in The Lancet, July 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#8 of 52,249)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 894 news outlets
blogs: 62 blogs
policy: 9 policy sources
twitter: 12493 X users
patent: 29 patents
peer_reviews: 1 peer review site
facebook: 41 Facebook pages
wikipedia: 18 Wikipedia pages

reddit: 58 Redditors
f1000: 1 research highlight platform
q&a: 3 Q&A threads
video: 10 YouTube creators
guideline: 6 clinical guideline sources
bluesky: 1 Bluesky user
podcasts: 6 podcasts

Readers on

mendeley: 3422 Mendeley

So far, Altmetric has seen 29 patents that reference this research output.

Ionizable lipids and methods of manufacture and use thereof

Grant US-12576040-B2

United States of America

Methods of lipid nanoparticle manufacture and compositions derived therefrom

Grant US-12458604-B2

United States of America

TREATMENT AND PREVENTION OF LUNG CANCER

Application WO-2025149656-A1

World Intellectual Property Organisation (WIPO)

Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2…

Grant US-12216120-B2

United States of America

Coronavirus vaccine

Grant US-12208136-B2

United States of America

Coronavirus vaccine

Grant US-12186387-B2

United States of America

Coronavirus vaccine

Grant US-12133899-B2

United States of America

THERAPEUTIC RNAs

Application WO-2024213874-A1

World Intellectual Property Organisation (WIPO)

Antibodies capable of binding to the spike protein of coronavirus SARS-CoV-2

Grant US-12030927-B2

United States of America

Coronavirus vaccine

Grant US-11925694-B2

United States of America

METHOD FOR PURIFYING VIRUS

Application US-20240035002-A1

United States of America

Coronavirus vaccine

Grant US-11878055-B1

United States of America

SARS-CoV-2 antigens and uses thereof

Grant US-11872279-B2

United States of America

ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CORONAVIRUS SARS-COV-2

Application WO-2023156636-A1

World Intellectual Property Organisation (WIPO)

ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CORONAVIRUS SARS-COV-2

Application EP-4230650-A1

European Patent Office

Coronavirus vaccine

Grant US-11547673-B1

United States of America

Polypeptides, compositions and uses thereof for treating infection or limiting the…

Application KR-20220142472-A

Republic of Korea

IMMUNE CELL COUNTING OF SARS-COV-2 PATIENTS BASED ON IMMUNE REPERTOIRE SEQUENCING

Application WO-2022207682-A1

World Intellectual Property Organisation (WIPO)

NOVEL COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE

Application WO-2022178545-A1

World Intellectual Property Organisation (WIPO)

Immunomodulatory anti-CD73 antibodies and uses thereof

Application KR-20220107196-A

Republic of Korea

COMPOSITIONS AND METHODS FOR DIAGNOSING SARS-COV-2 (COVID-19) AND FOR MONITORING SARS-COV-2…

Application WO-2022120216-A1

World Intellectual Property Organisation (WIPO)

EXTRACELLULAR VESICLES HARBORING A SPIKE PROTEIN, NUCLEIC ACIDS FOR PRODUCING THE SAME…

Application EP-3973985-A1

European Patent Office

Novel coronavirus vaccine based on chimpanzee adenovirus expression spike protein

Application CN-114164185-A

China

Vaccines based on an antigen protein fused to a nanostructuring scaffold

N/A LU-102016-B1

Luxembourg

CORONA VIRUS SPIKE PROTEIN-TARGETING ANTIBODIES AND USE THEREOF

Application WO-2022023292-A2

World Intellectual Property Organisation (WIPO)

STRUCTURE-GUIDED IMMUNOTHERAPY AGAINST SARS-COV-2

Application WO-2021247925-A1

World Intellectual Property Organisation (WIPO)

BETACORONAVIRUS PROPHYLAXIS AND THERAPY

Application WO-2021219897-A1

World Intellectual Property Organisation (WIPO)

COMPOSITIONS AND METHODS TARGETING CORONAVIRUSES

Application WO-2021201679-A1

World Intellectual Property Organisation (WIPO)

MEASLES-VECTORED COVID-19 IMMUNOGENIC COMPOSITIONS AND VACCINES

Application WO-2021160850-A1

World Intellectual Property Organisation (WIPO)